choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Eloxatin

Eloxatin Newsletter
  • Atezolizumab, Immunogenic Chemotherapy Combination Shows Promise for DLBCL Treatment 14 Mar 2025 23:57 GMT

    … (Rituxan), gemcitabine (gemzar), and oxaliplatin (eloxatin; GemOx; R-GemOx+Atezo) has … RT. The multicenter phase 1 trial included centers at Emory University …

  • Zolbetuximab-clzb Receives FDA Approval for Treatment of Advanced Gastric and GEJ Adenocarcinoma 19 Oct 2024 00:07 GMT

    … granted FDA approval for the treatment of patients … and GLOW (NCT03462719) trials which both met their … trial, the researchers evaluated zolbetuximab-clzb in combination with oxaliplatin (Eloxatin … at Harvard Medical School, medical oncologist at Massachusetts …

  • Eloxatin dosage 18 Mar 2024 19:22 GMT

    … (FDA) to treat: Eloxatin belongs to a drug class called platinum-based chemotherapy drugs. Eloxatin … mg or 100 mg of medication. Your healthcare professional will choose … the best treatment plan for you. The Eloxatin dosage your doctor prescribes will …

  • Drug Regimen Boosts Survival of People with Advanced Colorectal Cancer 24 May 2023 20:15 GMT

    … Drug Administration (FDA) for the treatment of some people with colorectal cancer. The trial … New England Journal of Medicine on May 4. … Eloxatin), bevacizumab or another drug that blocks VEGF, and/or a drug … shown in phase 2 trials of the combination, “ …

  • Fueling A Focused Drug Development Model 01 Nov 2022 09:54 GMT

    … oncology products to market: Eloxatin (oxaliplatin) and Trelstar ( … and subcontracted medicinal chemistry. Our second pillar is drug delivery, … life sciences, including pharmaceuticals and our investments in … sensor data in clinical trials. Patients shouldn’t …

  • Eloxatin (oxaliplatin) 12 Aug 2022 14:12 GMT

    … bothersome. Note: The Food and Drug Administration (FDA) tracks side effects of … effect in clinical trials of the medication. Allergic reactions from Eloxatin can be … you treatments to ease your symptoms. Your doctor will also stop prescribing Eloxatin …

  • Risk of Peripheral Neuropathy From Abraxane, Eloxatin, Increased By Certain Risk Factors: Study 16 Feb 2021 23:39 GMT

    Side effects of chemotherapy drugs like Abraxane and Eloxatin may also increase the … published this week in the medical journal JAMA Network Open, Australian … (CIPN) from Abraxane, Eloxatin and other neurotoxic cancer treatment drugs. The study involved …

  • Colorectal Cancer Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight 11 Dec 2020 19:57 GMT

    … companies covered: Roche Spectrum Pharmaceutical Sanofi Aventis Genentech Eli … cancer Drugs covered: Capecitabine (Xeloda) Fluorouracil (5-FU) Oxaliplatin (Eloxatin) … Patient Population 8. Treatment Algorithm, Current Treatment, and Medical Practices 8.1. …

  • Cancer Generics Industry – Treatment, Outlook, Analysis, Research, Review To 2025 12 Aug 2020 07:13 GMT

    … on –“ Cancer Generics Industry – Treatment, Outlook, Analysis, Research, Review … the major cancer generic drugs available in the global … Mylan N.V Sun Pharmaceutical Industries Ltd Sanofi Dr. … Irinotecan Hydrochloride) 6.2.2 Eloxatin (Oxaliplatin) 6.2.3 …

  • Sarcopenia Shows Association to Higher Risk of Chemotherapy-Induced Peripheral Neurotoxicity 20 May 2025 17:11 GMT

    … vedotin (Adcetris, n = 51), oxaliplatin (Eloxatin, n = 34), or paclitaxel (Abraxanen … <.001) were observed after treatment. Notably, researchers observed no significant … et al. Association of pre-treatment sarcopenia with clinically relevant chemotherapy …

Satisfied with the content?

Continue to create your account.